Full-Time

VP – Digital Product & Ecommerce

Seed Health

Seed Health

201-500 employees

Develops and sells probiotic microbiome products

Compensation Overview

$250k - $275k/yr

+ Equity

Remote in USA

Remote

Category
Product (1)

Get referred to Seed Health

See people who can refer or advise you

Requirements
  • You have 8+ years of digital product and ecommerce experience, with meaningful depth in direct-to-consumer, conversion optimization, or subscription businesses at scale.
  • You have defined product strategy from ambiguity, articulating what the product should become and building organizational conviction around that vision.
  • You lead cross-functional teams by setting strategic direction, with Engineering, Design, and Commercial partners looking to you for the 'what' and 'why' rather than just the 'when'.
  • You connect experience decisions to business outcomes and can articulate tradeoffs clearly to executive stakeholders.
  • You are analytically fluent, comfortable with conversion rate optimization modeling, cohort analysis, and experiment design, and you use data to sharpen strategic bets, not just measure outputs.
  • You operate with urgency and proactive judgment, reframing or escalating when work stalls rather than letting it drift.
  • You are opinionated and substantive, but intellectually honest, forming strong hypotheses and updating them when evidence says otherwise.
  • You hold a high bar for craft and brand expression, understanding premium digital experience is a commercial differentiator.
  • You are a clear, structured communicator who can make complex strategy legible to senior stakeholders and cross-functional partners.
Responsibilities
  • Set the vision and standard for Seed's digital experience across web and app — conversion-optimized, brand-forward, and technically excellent.
  • Drive the product roadmap in close partnership with Engineering and Design, with clear accountability for delivery, quality, and measurable results.
  • Own the A/B testing and experimentation program, translating learnings into improvements in CVR, AOV, and LTV.
  • Champion site performance, accessibility, and speed as non-negotiables.
  • Own discount and incentive architecture, subscription mechanics, and upsell strategy.
  • Lead on-site merchandising — how products are featured, sequenced, and sold.
  • Partner with Product Marketing on pricing dynamics and ensure on-site execution reflects broader commercial strategy.
  • Translate audience segmentation into personalized digital experiences.
  • Own the digital execution for all product launches — premium, cohesive, commercially effective.
  • Serve as the primary digital product voice across DTC, pricing, channel, and commercial planning conversations.
  • Drive alignment across Engineering, Design, Creative, and Performance on shared priorities.
  • Build a high-performing, increasingly autonomous team — operating at the strategic level, not in execution.
Desired Qualifications
  • Bonus: experience in health, wellness, or consumer brands with premium positioning; familiarity with Shopify ecosystem or subscription platforms; exposure to personalization systems or agentic commerce

Seed Health develops and sells probiotic and microbiome-based consumer products for humans and pets through its online store. Formulations are grounded in scientific research, tested for safety and effectiveness, and shipped directly to customers. The company differentiates itself by pairing rigorous science with education and transparent communication, while pursuing a direct-to-consumer model and a broader focus on planetary health. Its goal is to improve human and planetary health by making microbiome science actionable and accessible for everyday wellness.

Company Size

201-500

Company Stage

Series A

Total Funding

$40M

Headquarters

Los Angeles, California

Founded

2016

Get referred to Seed Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • First CMO and Seed University support scalable brand growth.
  • Revenue growth above 500% in three years shows strong consumer demand.
  • Resilient Soils Project creates proprietary environmental microbiome data and partnerships.

What critics are saying

  • Premium subscription pricing faces cheaper probiotics and private-label substitution.
  • Single flagship product concentration magnifies any safety or efficacy setback.
  • Retail expansion increases dependence on Target, Amazon, and Sprouts algorithms.

What makes Seed Health unique

  • Research-first microbiome company commercializing clinically validated biotics under Seed.
  • Combines DTC, Target, Amazon, and Sprouts distribution for omnichannel reach.
  • Extends microbial science into therapeutics, consumer health, and environmental solutions.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

401(k) Company Match

Mental Health Support

Wellness Program

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
PR Newswire
May 5th, 2025
Seed Health Presents New Clinical Trial Data: Ds-01® Increases Two Key Microbiome Molecules Linked To Gut, Metabolic, Immune, And Cellular Health

DS-01® is the first broad-spectrum synbiotic clinically shown to increase production of both Urolithin A and butyrate—two key microbial metabolites linked to whole-body healthPresented at Digestive Disease Week® (DDW) 2025, the findings expand DS-01®'s clinical foundation and reinforce the potential of microbiome-targeted products to impact multiple biological systemsBOSTON, May 5, 2025 /PRNewswire/ -- Microbiome science company Seed Health presented clinical data on its flagship innovation, DS-01® Daily Synbiotic, at Digestive Disease Week® (DDW) 2025. Findings from a randomized, placebo-controlled clinical trial in healthy adults demonstrated that DS-01® increased production of two key microbial metabolites—Urolithin A and butyrate—implicated in gut barrier function, metabolism, and healthy aging. The trial also found reductions in C-Reactive Protein (CRP), a widely used marker of systemic inflammation, suggesting DS-01®'s potential to influence immune pathways. The findings underscore DS-01®'s impact beyond microbial composition, demonstrating measurable biological function through the production of microbiome-mediated metabolites.The company presented two posters during the "Prebiotics, Probiotics and Synbiotics in Health and Disease" session.Presentation HighlightsEffects of a novel, broad-spectrum synbiotic on Urolithin A production: A randomized, placebo-controlled clinical trialThis randomized, placebo-controlled clinical trial evaluated DS-01® for its ability to increase production of Urolithin A—a microbiome-derived metabolite linked to mitochondrial function, cellular energy, metabolic health, intestinal barrier integrity, and healthy aging. DS-01® provides the natural machinery to produce Urolithin A, delivering both a polyphenol precursor in its prebiotic outer capsule and key microbes in its probiotic inner capsule.Overall, this is the first study to demonstrate that a broad-spectrum synbiotic can increase Urolithin A production in humans. Key findings include:Rapid and Sustained Urolithin A Increase: DS-01® increased urinary Urolithin A levels by approximately 100-fold by Day 7 (P<0.0001), with levels sustained through Day 91.DS-01® increased urinary Urolithin A levels by approximately 100-fold by Day 7 (P<0.0001), with levels sustained through Day 91

The Chalkboard Mag
Aug 8th, 2024
I Tried Seed Health's New Vaginal Probiotic-Here's Why You Should Too

(In fact, one of its editors previously covered the Daily Synbiotic at The Chalkboard Mag) But it wasn't until Seed Health launched its VS-01(TM) Vaginal Synbiotic that I decided to give the brand a try to rebalance my microbiome and the rest of my system.

PR Newswire
Aug 1st, 2024
New Clinical Data Highlights Efficacy Of Seed Health'S Vs-01 Vaginal Synbiotic In Establishing Protective And Optimal Vaginal Microbiome

The study, which is the first to show that a multi-strain vaginal synbiotic can establish a protective vaginal environment, will be presented at the Annual Meeting of the Infectious Diseases Society for Obstetrics and Gynecology (IDSOG)The data demonstrate that VS-01™ successfully cultivates a vaginal microbiome dominated by Lactobacillus crispatus, reduces harmful microbes, and combats vaginal dysbiosisThese results underscore the potential of the vaginal microbiome and microbiome-directed innovations to redefine standards of care in women's healthBOSTON, Aug. 1, 2024 /PRNewswire/ -- Seed Health will present new clinical data on its flagship vaginal microbiome innovation, VS-01™ Vaginal Synbiotic, at the upcoming 2024 Infectious Diseases Society for Obstetrics and Gynecology (IDSOG) Annual Meeting. Data from a randomized, placebo-controlled clinical trial demonstrated the superior efficacy of VS-01™ in cultivating a stable and healthy vaginal microbiome. The synbiotic successfully established a protective environment dominated by Lactobacillus crispatus and inhibited harmful microbes associated with vaginal dysbiosis and inflammation. These findings highlight the transformative potential of proactive, preventive care centered on the vaginal microbiome, shifting the focus from traditional symptom management to maintaining a balanced and resilient vaginal ecology.A landmark 2012 study from vaginal microbiome researcher Jacques Ravel, Ph.D., demonstrated that the most stable and optimal vaginal microbiome is characterized by a dominance of the bacterium Lactobacillus crispatus, which plays a protective role in maintaining vaginal health. However, everyday factors such as menstruation, sexual activity, exercise, stress, contraceptives, and cleansers can deplete the abundance of L

Forbes
May 23rd, 2024
LA-Based Probiotic Company Hones In On Vaginal Health

LA-based probiotic company Seed is launching a new vaginal suppository that will help women maintain a more stable vaginal microbiome.

PR Newswire
May 21st, 2024
Seed Health Launches Vs-01, A First-Of-Its Kind Vaginal Microbiome Innovation To Redefine Vaginal Care

An optimal vaginal microbiome is a key driver of gynecological, urogenital, and reproductive healthVS-01™ is a multi-strain probiotic and prebiotic clinically validated to establish an optimal vaginal microbiome and sustain regulated vaginal pHBuilt on the research of renowned vaginal microbiome scientist Dr. Jacques Ravel, VS-01™ is the first to pioneer a microbial genomics approach powered by the most comprehensive host-microbiome vaginal data setLOS ANGELES, May 21, 2024 /PRNewswire/ -- Seed Health , a microbiome science company, today launched VS-01™ Vaginal Synbiotic, the first vaginal synbiotic clinically validated to rapidly establish an optimal vaginal microbiome dominated by Lactobacillus crispatus, the vagina's most protective bacteria. Dr. Jacques Ravel's pioneering research has elucidated the crucial role of the vaginal microbiome in gynecological, urogenital, and reproductive health, though everyday factors like stress, sex, menstruation, and diet can disrupt its equilibrium and deplete the abundance of L. crispatus. Dr